Figure 6
Recurrence-free survival difference between pathological responders and non-responders using the optimised threshold of 46.5% reduction in SUVmax.
Figure 6 | Scientific Reports
Recurrence-free survival difference between pathological responders and non-responders using the optimised threshold of 46.5% reduction in SUVmax.
